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Summary
In 60 tuberculosis patients with diabetes mellitus and autoimmune thyroiditis serum level of selenium, thyroid state 
and immunological indexes were studied. Low level of selenium, subclinical hypothyroidism and weaken immunological 
response toward tuberculosis were diagnosed. Prescribing of selenite sodium with 200 µ daily during 2 months normal-
ized serum level of selenium, restored thyroid function and improved immunological response. Inclusion of selenite 
sodium in complex therapy of tuberculosis patients with diabetes mellitus and autoimmune thyroiditis after examination 
of serum level of selenium and thyroid state is recommended.
Key-words: tuberculosis, co-infection, diabetes mellitus, autoimmune thyroiditis.
Резюме. Влияние нитрата селена на показатели иммунитета у больных туберкулезом с сахарным диа-
бетом и аутоиммунным тиреоидитом
У 60 больных туберкулезом с сахарным диабетом и аутоиммунным тиреоидитом изучались уровень селе-
на в сыворотке крови, тиреоидный статус и показатели иммунитета. Диагностирован низкий уровень селена, 
субклинический гипотиреоз и снижения иммунного ответа на туберкулезную инфекцию. Назначение селенита 
натрия по 200 мг ежедневно в течение 2 месяцев нормализовало уровень селена в сыворотке крови, восстановило 
функцию щитовидной железы и улучшило иммунологический ответ. Рекомендуется включение селенита натрия 
в комплексную терапию пациентов с туберкулезом с сахарным диабетом и аутоиммунным тиреоидитом после 
исследования уровня селена в сыворотке крови тиреоидного статуса.
Ключевые слова: туберкулез, сахарный диабет, аутоиммунный тиреоидит.
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Rezumat. Influența selenitului de sodiu asupra indicilor imunologici ai pacienților cu tuberculoză cu diabet 
zaharat și tiroidită autoimună
La 60 de pacienți cu tuberculoză cu diabet zaharat și tiroidită autoimună, s-a studiat nivelul seric de seleniu, starea 
tiroidiană și indicii imunologici. A fost diagnosticat un nivel scăzut de seleniu, hipotiroidismul subclinic și un răspuns 
imunologic slab față de tuberculoză. Prescrierea de selenit de sodiu cu 200 µ pe zi pe parcursul a 2 luni a normalizat ni-
velul seric de seleniu, a restabilit funcția glandei tiroide și a îmbunătățit răspunsul imunologic. Se recomandă includerea 
selenitului sodic în terapia complexă a pacienților cu tuberculoză cu diabet zaharat și tiroidită autoimună după examinarea 
nivelului seric de seleniu și a stării tiroidiene.
Cuvinte-cheie: tuberculoză, diabet zaharat, tiroidită autoimună.
Introduction. Convergence of the two world 
epidemics: tuberculosis and diabetes justify the rel-
evance of the study of the features of the running of 
tuberculosis with comorbid diabetes [1]. Diseases 
of the thyroid gland are found in patients with dia-
betes mellitus in 11-30% [6, 9, 10]. Hypothyroidism 
against the background of autoimmune thyroiditis 
worsens the outcomes of anti-tuberculosis chemo-
therapy [7] due to the suppressive effect of thyroid 
hormone deficiency on T-cell immunity [2]. Howev-
er, not only iodine is needed for the normal function-
ing and maintenance of thyroid homeostasis, but also 
selenium. The selenium content in 1 g of thyroid tis-
sue is greater than in other organs [8]. in the regions 
with a heavy iodide deficiency, the selenium deficien-
cy is weighting hypothyroidism and leads to myxede-
ma [11]. With autoimmune thyroid, in conditions of 
selenium deficiency, there was an inverse relationship 
between the level of selenium in the blood and the 
thyroid function [8,11]. Most authors pay attention to 
the positive effect of selenium additives on the im-
mune system [4, 5].
The object of the study to detail the influence of 
selenite sodium on immunological indexes in tuber-
culosis patients with diabetes mellitus and autoim-
mune thyroiditis with subclinical hypothyroidism.
Materials and methods. The study included 60 
patients with pulmonaryberculosis (TB) with con-
comitant diabetes mellitus (DM) and autoimmune 
thyroiditis. The patients were divided in 2 groups: 
30 patients in observation group received 200 μg 
of selenite sodium every day during 2 months of 
the intensive phase simultaneously with antituber-
culosis chemotherapy and other 30 patients of con-
trol group received antituberculosis chemotherapy 
only. Therapy for compensation for carbohydrate 
exchange was carried out in both groups. All pa-
tients were diagnosed with infiltrative destructive 
pulmonary tuberculosis and type I or II diabetes 
mellitus with secondary insulin dependence, and 
women predominated. Before starting treatment 
and at the end of intensive phase, serum levels of 
selenium in the laboratory “Synevo” (Germany) on 
the analyzer “PERKIN ELMER ZEEMAN AAS 
4110”, free thyroxine (free T4), thyroid-stimulating 
hormone of the pituitary gland (TSH), antibodies 
to thyroglobulin (TG) and thyroperoxidase (TPO) 
were determined by the immunoenzymatic method. 
At the same time, the parameters of cellular and 
humoral immunity were studied in patients of both 
groups. The state of T- and B-systems of immunity, 
natural killers was assessed. Phenotyping of lym-
phocytes was carried out and the relative content of 
T cells was determined: CD3 +, T-helpers (CD4+), 
cytotoxic T-cells (CD4 +), B-lymphocytes (CD19+) 
and natural killer cells (CD16+). Using Vector Best 
reagents, the cytokine profile was determined: the 
levels of tumor necrosis factor-α (TNF-α), interfer-
on-γ (INT-γ), interleukin-2 (Il-2), -6 (Il-6) and -4 
(Il-4) before starting treatment and at the end of in-
tensive phase. Statistical processing of the obtained 
data was carried out by the method of variation sta-
tistics using a standardized package of calculations 
Microsoft Excel XP. The probability of discrepancy 
between the mean values  was determined by the 
Student’s t test. The critical level of significance (P) 
when testing statistical hypotheses was taken equal 
to 0.05.
Results. The results of the study of the serum 
level of selenium and the hormonal profile of both 
groups are presented in Table 1.
In both groups of patients with tuberculosis with 
concomitant diabetes and AIT with SH low level of 
selenium was marked. in taking of selenite sodium 
during 2 months normalized the serum level of sele-
nium and restored of thyroid function
In both groups of patients with tuberculosis with 
concomitant diabetes and AIT before the start of 
treatment, low-normal values  of free thyroxine are 
noted. At the same time, these patients also registered 
pathologically high initial levels of thyroid stimulat-
ing hormone (Table 1). These changes indicate the 
presence of a subclinical hypothyroidism (SH) with 
tuberculosis with concomitant diabetes mellitus and 
structural disorders of the thyroid gland by the type 
of autoimmune thyroiditis. There were no deviations 
from the norm at the initial level of antibodies to 
thyroglobulin in both groups. However, a high lev-
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el of antibodies was recorded to thyroperoxidase in 
groups of patients with tuberculosis with concomi-
tant diabetes and AIT with SH before the treatment 
began. Thus, the identified changes correspond to 
the autoimmune thyroid in these patients not only on 
the basis of a specific change in echograms, but also 
on the basis of both a hormonal criterion (subclini-
cal hypothyroidism, most often accompanying au-
toimmune thyroiditis in the deployed stage) and on 
the basis of an immunological criterion (an increase 
in antibodies to TPO). in the serum of patients of 
both groups with lung tuberculosis with concomi-
tant diabetes and autoimmune thyroiditis, a reduced 
selenium level was installed (Table 1).
At the end of the intensive therapy phase with 
the inclusion of sodium selenite in the observation 
group, the level of selenium level is noted: from 
(58.23 ± 6.54) μg / ml to (108.42 ± 8.12) μg / ml; 
Free thyroxine levels: from (8.60 ± 1.69) PMOL / L 
to (12.45 ± 1.58) PMOL / L and thyroid stimulating 
hormone from (4.37 ± 0.91) MCED / ml to ( 2.28 ± 
0.78) MCED / ml, as well as decreased to the per-
missible values  of the antibody titer to thyroperoxi-
dase from (136.16 ± 8.96) un / ml to (34.54 ± 8.27) 
U / ml. in this case, a low level of selenium remains 
in the comparison group: (60.31 ± 7.50) μg / ml and 
(62.20 ± 5.4) μg / ml and against the background of 
chemotherapy there is a further decrease in the level 
of free thyroxine compared to the initial level (8.24 
± 1.71) PMOL / L TO (6.87 ± 1.67 PMOL / L), still 
there is a high level of thyroid stimulating hormone 
(4.51 ± 0.87) MCED / ml and (4.82 ± 0.91) MCED 
/ ml. Thus, the appointment of sodium selenite for 2 
months leads to normalization of the selenium level 
in patients with tuberculosis against the background 
Table 1
The results of the study of the serum level of selenium and the hormonal profile in tuberculosis patients with 
concomitant diabetes mellitus and autoimmune thyroiditis with subclinical hypothyroidism
Groups of patients
Observation group (n=30) Control (n=30)
Before treatment 2 months later Before treatment 2 months later
Т4 free (pmol/l) 8,60 ± 1,69 12,45 ± 1,58* 8,24 ± 1,71 6,87± 1,67#
TSH (IU/ml) 4,57 ± 0,91 2,28 ± 0,78* 4,51 ± 0,87 4,82 ± 0,91#
Antibodies to TG (U/ml) 8,67 ± 5,56 8,34 ± 5,66 8,15 ± 5,62 8,56 ± 5,34
Antibodies to TPO (U/ml) 136,16±8,96 34,54±8,27* 140,54±8,79 142,32±8,04#
Selenium (µ/ml) 58,23±6,54 108,42±8,12* 60,31±7,50 62,20±5,46#
Note:* – a reliable difference în indicators between groups (p≤0,5); # – a reliable difference în indicators before and 2 months 
later (p≤0,5).
of endocrine pathology and restores disturbed thyroid 
homeostasis.
The results of the study of immunological index-
es in tuberculosis patients with concomitant diabetes 
mellitus and autoimmune thyroiditis with subclinical 
hypothyroidism are present in table 2. 
The study of the immune system reveals devia-
tions in the parameters of initial cellular immunity in 
both groups. 2 months later in the observation group, 
has been receiving selenite sodium there was a sig-
nificant increase of leukocytes, mononuclear cells 
and pan-lymphocytes (CD3+) in comparison with the 
control. The levels of the subpopulations of T-help-
ers (CD4+) and IRI also were increased in patients of 
observation group. (Table 2). The levels of immuno-
globulins G, A and M were increased to the end of 
intensive phase in observation group compared with 
the control. 
In TB patients with DM+AIT of observation group, 
the level of TNF-α increased more than twice after re-
ceiving selenite sodium. The level of INT-γ increased 
in 2.3 times more in observation group when compared 
with control group. The content of IL-2 in the systemic 
blood flow of TB/DM patients of observation group in-
creased of 2.5 times compared with the control. 
Level of IL-4 in TB patients with DM and AIT 
and SH of observation group decreased compared 
with the control group. 
Discussion. Thus, the results of the study demon-
strate an improving change in all branches of immu-
nity in tuberculosis patients with DM and AIT with 
SH after 2 months receiving of selenite sodium. In-
tensifying of the immunity were accompanied by 
stimulation of thyroid function under the influence of 
selenite sodium. So, selenite stimulates both humoral 
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and cellular immunity by restoring thyroid function. 
These results, as well as data of the effect of admin-
istration of thyroid hormone in vivo and in vitro, in-
dicate an important role of thyroid hormones in mod-
ulating the activity of natural killer cells. The results 
are corresponding with other studies. [3,9], showing 
a positive association of thyroid hormone concentra-
tion with inflammatory markers activated by T-cells, 
NK-interleukin-6 expression by activated monocytes, 
and a higher density of interleukin-2 receptors in T 
cells and thus shedding light on the mechanisms by 
which the endocrine system is able to influence the 
severity of immunity.
Table 2
The results of the study of immunological indexes în tuberculosis patients with concomitant diabetes mellitus  
and autoimmune thyroiditis with subclinical hypothyroidism
Groups
Observation group (n=30) Control group (n=30)
Before treatment 2 months later Before treatment 2 months later
Leucocytes,109/l 5,34 ±0,82 7, 78± 0,92 5,67 ±0,69 5,65 ±0,55 
Monocytes,% 31,45±3,21 41,32± 2,54 32,05±2,98 33,45±2,76 
CD3+ 43,27±2,89  58,43± 3,3 44,56±2,44   45,23±2,89*  
CD4+ 25,35±2,76   35,87±3,8 26,23±2,45   26,33±2,65*  
CD8+ 16,32±1,92 18,66±1,78  17,73±1,43 17,35±1,47 
IRI 1,37±1,78 1,92±1,87 1,48±1,65 1,52±1,45 
CD19+ 13,38±2,84 18,76±1,59 14,83±2,48 14,33±2,43 
NK-cells(CD16+) 14,83±2,72 19, 89±1,76 14,83±2,72 16,45±2,65 
IgG 1,51±0,42 4,67±1,08 1,98±0,23 1,71±0,44* 
IgM 0,52±0,52 2,05±1,51 0,65±0,87 0,87±0,45* 
IgA 14,78±1,82 20,23±1,61 15,23±1,82 15,67±1,78* 
TNF-α (pmol/ml) 27.88 ±14.27 60.44 ±15,01 28.56 ±13.99 28.54 ±14.89*
INT-γ (pmol/ml) 2.33 ± 0.18 4.98 ± 0.54 2.67 ± 0.96 2.54 ± 0.84*
IL-2 (pmol/ml) 3.12 ± 0,50 7.09± 0.89 3.65 ± 0,81 3.21 ± 0,50*
IL-6 (pmol/ml) 14.89±1.18 39.66±1.44 15.32±1.18 15.21±1.81*
IL-4 (pmol/ml) 0.070±0,009 0.011±0,003 0.078±0,008 0.073±0,007*
Note: * – a reliable t difference în indicators between groups (p <0.05).
Conclusions
1. In tuberculosis patients with diabetes and AIT 
with subclinical hypothyroidism initially low serum 
level of selenium was marked. 
2. Selenite sodium in taken with 200 µ every day 
during 2 months normalized serum level of selenium 
and restored thyroid function
3. The indexes of both branches of the immunity 
improved by administration of selenite sodium during 
2 months.
4. Selenite sodium could be recommended for con-
comitant therapy in TB patients with DM and AIT after 
examination of serum level of selenium and thyroid state. 
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Rezumat 
Studiul a inclus 24 de pacienți, care au constituit lotul de bază – 12 pacienți cu tuberculoză pulmonară în asociere cu 
infecția COVID-19 și lotul de control – 12 pacienți cu tuberculoză pulmonară. S-a studiat formula leucocitară, conținutul 
de limfocite CD3, CD4, CD8, conținutul de NO2
−+NO3
− total și metaboliții săi. Rezultatele obținute au demonstrat, că la 
pacienții cu tuberculoză pulmonară asociată cu COVID-19 se determină o scădere pronunțată a limfocitelor și o deplasare 
nesemnificativă a formulei leucocitare spre stânga, Conținutul limfocitelor scad datorită limfocitelor CD3 și subpopulației 
acestora de limfocite CD4 (helper). Indicele de imunoreglare CD4/CD8 demonstrează stimularea rectivității imunologice 
la pacienții cu tuberculoză pulmonară și depresie a reactivității imunologice la pacienții cu tuberculoză pulmonară aso-
ciată cu infecția COVID-19 și o suprimare pronunțată a producției conținutului de NO2
− + NO3




Cuvinte-cheie: tuberculoză pulmonară, COVID-19, imunologie, biochimie.
Summary.  Particularities of immunological reactivity, nitric oxide and its metabolities production in patients 
with pulmonary tuberculosis in association with COVID-19 infection
The study included 24 patients, which formed the baseline group – 12 patients with pulmonary tuberculosis in com-
bination with COVID-19 infection and the control group – 12 patients with pulmonary tuberculosis. There were studied 
the leukocyte formula, the content of CD3, CD4, CD8 lymphocytes, the content of NO2
−+NO3
− total and its metabolites. 
The obtained results showed that in patients with pulmonary tuberculosis and COVID-19 there is a pronounced decrease 
of lymphocytes and an unexpressed shift of the leukocyte formula to the left. The lymphocyte content decreases due 
to CD3 lymphocytes and their subpopulation of CD4 (helper) lymphocytes. The CD4/CD8 immunoregulatory index 
demonstrates a stimulation of immunological reactivity in patients with pulmonary tuberculosis and depression of immu-
nological reactivity in patients with pulmonary tuberculosis in combination with COVID-19 infection and a pronounced 
suppression of the production content of NO2
−+NO3
− total and its metabolites (NO2
− and NO3
−).
Key-words: pulmonary tuberculosis, COVID-19, immunology, biochemistry.
